1. Home
  2. CUBA vs ACXP Comparison

CUBA vs ACXP Comparison

Compare CUBA & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUBA
  • ACXP
  • Stock Information
  • Founded
  • CUBA 1992
  • ACXP 2017
  • Country
  • CUBA United States
  • ACXP United States
  • Employees
  • CUBA N/A
  • ACXP N/A
  • Industry
  • CUBA Investment Managers
  • ACXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • CUBA Finance
  • ACXP Health Care
  • Exchange
  • CUBA Nasdaq
  • ACXP Nasdaq
  • Market Cap
  • CUBA 39.0M
  • ACXP 8.4M
  • IPO Year
  • CUBA N/A
  • ACXP 2021
  • Fundamental
  • Price
  • CUBA $2.52
  • ACXP $0.47
  • Analyst Decision
  • CUBA
  • ACXP Strong Buy
  • Analyst Count
  • CUBA 0
  • ACXP 2
  • Target Price
  • CUBA N/A
  • ACXP $10.00
  • AVG Volume (30 Days)
  • CUBA 93.9K
  • ACXP 18.7M
  • Earning Date
  • CUBA 01-01-0001
  • ACXP 08-08-2025
  • Dividend Yield
  • CUBA 20.83%
  • ACXP N/A
  • EPS Growth
  • CUBA N/A
  • ACXP N/A
  • EPS
  • CUBA N/A
  • ACXP N/A
  • Revenue
  • CUBA N/A
  • ACXP N/A
  • Revenue This Year
  • CUBA N/A
  • ACXP N/A
  • Revenue Next Year
  • CUBA N/A
  • ACXP N/A
  • P/E Ratio
  • CUBA N/A
  • ACXP N/A
  • Revenue Growth
  • CUBA N/A
  • ACXP N/A
  • 52 Week Low
  • CUBA $2.25
  • ACXP $0.30
  • 52 Week High
  • CUBA $4.14
  • ACXP $3.33
  • Technical
  • Relative Strength Index (RSI)
  • CUBA 52.95
  • ACXP 52.38
  • Support Level
  • CUBA $2.46
  • ACXP $0.45
  • Resistance Level
  • CUBA $2.55
  • ACXP $0.59
  • Average True Range (ATR)
  • CUBA 0.04
  • ACXP 0.08
  • MACD
  • CUBA 0.00
  • ACXP -0.01
  • Stochastic Oscillator
  • CUBA 63.64
  • ACXP 27.06

About CUBA Herzfeld Caribbean Basin Fund Inc. (The)

Herzfeld Caribbean Basin Fund Inc operates as a closed-end management investment company. The company's investment objective is to obtain long-term capital appreciation. The firm offers customized discretionary account management and fund management services to individual and institutional investors. The fund invests in equity and equity-linked securities of public and private companies, including United States-based companies, whose securities are traded principally on a stock exchange in a Caribbean Basin Country. The fund's revenue source is through the dividends it receives. Its investments are geographically allocated in the United States followed by Mexico, Puerto Rico, and other countries.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

Share on Social Networks: